HER2-Positive Colorectal Cancer: Novel Approaches - Episode 9

Audience Q&A: Best Practices in Managing HER2-Amplified CRC

May 5, 2023

Tanios Bekaii-Saab, MD, FACP, Mayo Clinic, Cathy Eng, MD, Vanderbilt University, Pashtoon M. Kasi, MD, MBBS, MS, Aparna R. Parikh, MD

Fielding questions from the audience, expert oncologists discuss clinical trials, molecular testing, and early-stage disease in the context of HER2-amplified colorectal cancer.

Video Player is loading.

Current Time 0:00

Duration 0:00

Loaded: 0%

Stream Type LIVE

Remaining Time 0:00

EP. 1: Colorectal Cancer: Prevalence, Workup, and Molecular Subtypes

EP. 2: Colorectal Cancer: An Overview on Molecular Profiling

EP. 3: Role of HER2 Expression in Colorectal Cancer

EP. 4: Role of Circulating Tumor DNA Testing in Colorectal Cancer

EP. 5: Treatment Algorithm for Metastatic Colorectal Cancer

EP. 6: HER2-Amplified Colorectal Cancer: Clinical Trial Data

EP. 7: Real-World Use of HER2-Directed Therapies in Colorectal Cancers

EP. 8: Evolutions in the HER2-Amplified CRC Treatment Landscape

Now Viewing

EP. 9: Audience Q&A: Best Practices in Managing HER2-Amplified CRC